Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
about
Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesAmerican association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: a retrospective cohort study.Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysisIs there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.Diabetes and sex: from pathophysiology to personalized medicine.Suitability of antiplatelet therapy in hypertensive patients.Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk.Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.
P2860
Q26747742-7E774F36-31B0-4691-9A7F-3C6F1EF28A90Q28384855-DCD654EC-472D-4E67-9C35-8A3901B071C4Q33949522-E6F751BF-0C20-481A-A220-2572716CFB78Q35136444-1660F0EE-4501-4842-A9A4-9C6AC7C0B974Q35527043-C4E11651-0DC8-4261-86C9-01D3E6C4501DQ35691400-CA5BD301-9F25-45D6-99DA-0CF5CB2B94CEQ36442945-3766C4D2-8F85-4777-8D7A-2501361B65F7Q38003113-E191DD66-A70D-4380-B271-2DE84CF653FFQ38052846-69EFF324-5F3C-40D0-9AA7-C32A5676DD04Q38201583-CBFF1DE6-ABED-405A-8C84-E0E42DB9E8ABQ44974747-8EFC04A5-6A26-4C9A-A5D0-5292114A5E53Q47878038-C431301C-3509-417C-A3C3-B251F4B68906
P2860
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Aspirin is associated with red ...... the Fremantle Diabetes study.
@ast
Aspirin is associated with red ...... the Fremantle Diabetes study.
@en
type
label
Aspirin is associated with red ...... the Fremantle Diabetes study.
@ast
Aspirin is associated with red ...... the Fremantle Diabetes study.
@en
prefLabel
Aspirin is associated with red ...... the Fremantle Diabetes study.
@ast
Aspirin is associated with red ...... the Fremantle Diabetes study.
@en
P2860
P356
P1433
P1476
Aspirin is associated with red ...... the Fremantle Diabetes study.
@en
P2093
Timothy M E Davis
P2860
P304
P356
10.2337/DC09-1701
P407
P577
2009-11-16T00:00:00Z